Drug Safety and Availability > FDA Drug Safety Communication: Safety Review of possible increased risk of blood clots with birth control pills containing drospirenone

FDA Drug Safety Communication: Safety review update on the possible increased risk of blood clots with birth control pills containing drospirenone

This update is in follow-up to the FDA Drug Safety Communication: Safety Review of possible increased risk of blood clots with birth control pills containing drospirenone on 5/31/2011.

Safety Announcement
Additional Information for Patients
Additional Information for Healthcare Professionals
Data Summary
Table